AXL expression in tumor tissues has been reported to correlate with tumor progression, poor prognosis, and drug resistance in various cancer and drug settings.21, 31, 32, 33, 34, 35 Therefore, AXL expression level has a potential to be utilized as a useful biomarker for patient survival and monitoring emerging resistance to treatment. This evidence concerns the gene AXL and cancer.